CALLIDITAS THERAPEUTICS earnings per share and revenue

LC8 earnings per share for the last quarter are -0.40 EUR whereas the estimation was -0.09 EUR which accounts for -366.38% surprise. Company revenue for the same period amounts to 25.58 M EUR despite the estimated figure of 32.10 M EUR. Estimated earnings per share for the next quarter are -0.04 EUR, and revenue is expected to reach 40.70 M EUR. Also watch annual changes over time to get a bigger picture of LC8 earnings per share and revenue dynamics.